Clinical trial
Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid…
NCT00186966 · Dutch Childhood Oncology Group, Other · Completed
Key facts
| NCT number | NCT00186966 |
|---|---|
| Title | Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia |
| Official title | A Randomized Phase III Study of the Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia |
| Lead sponsor | Dutch Childhood Oncology Group, Other |
| Collaborators | International BFM Study Group St. Jude Children's Research Hospital |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | Fludarabine, Cytarabine, Liposomal daunorubicin (DaunoXome), Etoposide, Thioguanine, Cyclophosphamide, Busulfan, Melphalan, Hematopoietic stem cell transplant, Total body irradiation |
| Enrollment | 394 |
| Start date | Mar 1, 2002 |
| Primary completion | Apr 1, 2009 |
| Completion | Sep 1, 2010 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 6, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: